Login
Subscribe
Mutational Signature Indicates Risk of Kidney Cancer Recurrence
Mutational Signature Indicates Risk of Kidney Cancer Recurrence
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.
kidney cancer
“Silent” Mutation Linked to Worse Kidney Cancer Outcome
Katarina Zimmer | Feb 17, 2021 | 6 min read
A synonymous mutation in the tumor suppressor gene BAP1 can result in loss of function of the protein without altering its amino acid sequence.
How Kidney Cancer Evolves
Jim Daley | Apr 18, 2018 | 2 min read
Renal cell carcinoma tumors have three different evolutionary fates, each associated with specific clinical outcomes.
Genome Digest
Kate Yandell | Aug 1, 2013 | 5 min read
What researchers are learning as they sequence, map, and decode species’ genomes